{"DataElement":{"publicId":"7607678","version":"1","preferredName":"Specimen Neoplasm Microarray Analysis Negation Collection Reason","preferredDefinition":"Text used to describe the reason why a specimen was not collected for neoplasm microarray analysis.","longName":"PRETRT_TUMARRY_REASND","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"7607676","version":"1","preferredName":"Specimen Neoplasm Microarray Analysis Negation Collection","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins)._An operation in which a term denies or inverts the meaning of another term or construction._The act of gathering things together; having been brought together in one place.","longName":"2241613v1.0:7607674v1.0","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7607674","version":"1","preferredName":"Neoplasm Microarray Analysis Negation Collection","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).:An operation in which a term denies or inverts the meaning of another term or construction.:The act of gathering things together; having been brought together in one place.","longName":"C3262:C18477:C25594:C25453","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Microarray Analysis","conceptCode":"C18477","definition":"Analysis using microarray technology (e.g., cDNA arrays to see gene expression or protein microarrays to profile the pattern of proteins).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE229D12-CB3E-5650-E053-4EBD850A6697","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-22","modifiedBy":"ONEDATA","dateModified":"2021-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE229D12-CB4F-5650-E053-4EBD850A6697","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-22","modifiedBy":"COLLIED","dateModified":"2021-04-07","changeDescription":"Curated for AMC 108 protocol DC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7349757","version":"1","preferredName":"Specimen Negation Collection Reason","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._An operation in which a term denies or inverts the meaning of another term or construction._The act of gathering things together; having been brought together in one place._An explanation of the cause of some phenomenon or action.","longName":"7349757v1.0","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not required by protocol","valueDescription":"Not required by protocol","ValueMeaning":{"publicId":"7349758","version":"1","preferredName":"Not required by protocol","longName":"7349758","preferredDefinition":"Not required by protocol","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9E94A8E-E7B6-0570-E053-4EBD850A8917","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9E94A8E-E7CF-0570-E053-4EBD850A8917","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","deletedIndicator":"No"},{"value":"Participant refused","valueDescription":"Participant refused","ValueMeaning":{"publicId":"3357955","version":"1","preferredName":"Participant refused","longName":"3357955","preferredDefinition":"Participant refused","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6E5A09C-AD3E-3491-E040-BB89AD43242E","latestVersionIndicator":"Yes","beginDate":"2012-01-19","endDate":null,"createdBy":"ALAIS","dateCreated":"2012-01-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9E94A8E-E7D9-0570-E053-4EBD850A8917","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","deletedIndicator":"No"},{"value":"Clinical error","valueDescription":"Clinical error","ValueMeaning":{"publicId":"7349759","version":"1","preferredName":"Clinical error","longName":"7349759","preferredDefinition":"Clinical error","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9E94A8E-E7E3-0570-E053-4EBD850A8917","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9E94A8E-E7FC-0570-E053-4EBD850A8917","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9E94A8E-E806-0570-E053-4EBD850A8917","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7349756","version":"1","preferredName":"Specimen Negation Collection Reason","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:An operation in which a term denies or inverts the meaning of another term or construction.:The act of gathering things together; having been brought together in one place.:An explanation of the cause of some phenomenon or action.","longName":"C19157:C25594:C25453:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A9E94A8E-E78F-0570-E053-4EBD850A8917","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"ONEDATA","dateModified":"2020-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A9E94A8E-E7A0-0570-E053-4EBD850A8917","latestVersionIndicator":"Yes","beginDate":"2020-07-08","endDate":null,"createdBy":"ALAIS","dateCreated":"2020-07-08","modifiedBy":"TAYLORT","dateModified":"2020-10-19","changeDescription":"10.19.2020 TL moved AI from APPRVD FOR TRIAL USE to RELEASED in preparation of MDR.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312661","version":"1","longName":"Lab","context":"AMC"}]}],"AlternateNames":[{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"D21C1_TUMARRY_REASND","type":"OID, AMC","context":"AMC"},{"name":"MCRO_ARRY_NO_CLLCT_RSN","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"If \"No\", specify the reason","url":null,"context":"AMC"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE22B628-BF09-037F-E053-4EBD850A6B1B","latestVersionIndicator":"Yes","beginDate":"2021-03-22","endDate":null,"createdBy":"COLLIED","dateCreated":"2021-03-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"Curated for AMC 108 protocol DC","administrativeNotes":"8/16/23_Added Short Name with rep term as part of CDE cleanup_smt","unresolvedIssues":null,"deletedIndicator":"No"}}